Insider Transactions in Q2 2021 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2021
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,500
-46.22%
|
$1,197,000
$266.56 P/Share
|
|
Jun 07
2021
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+31.61%
|
$378,000
$84.86 P/Share
|
|
May 06
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Open market or private sale
|
Direct |
2,500
-24.17%
|
$690,000
$276.55 P/Share
|
|
May 03
2021
|
Jean Luc Belingard Director |
SELL
Open market or private sale
|
Direct |
2,600
-14.31%
|
$699,400
$269.16 P/Share
|
|
May 03
2021
|
Jean Luc Belingard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+12.52%
|
$254,800
$98.49 P/Share
|
|
Apr 03
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct |
452
-4.19%
|
$113,904
$252.67 P/Share
|
|
Apr 03
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+8.56%
|
-
|